County
Hays County ESD 9 EMS
Drugs and doses41
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Gluconate, Cefazolin8
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500 mg | PO | not captured | standing | pages 82, 130 |
| Other | peds | 15 mg/kg | PO | not captured | standing | pages 82, 130 |
| Other | peds | 15 mg/kg | IV/IO | not captured | standing | pages 93, 130, 135 |
| Mild to moderate pain | adult | 500 mg | PO | not captured | standing | pages 82, 130, 134 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 82, 130, 134 |
| Mild to moderate pain | peds | 15 mg/kg | IV/IO | not captured | standing | pages 82, 130, 134 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12 mg | IV/IO | not captured | standing | page 72 |
| Other | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 125 |
| Narrow-complex tachycardia | adult | 12 mg | IV/IO | not captured | standing | pages 72, 125, 126 |
| Narrow-complex tachycardia | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 72, 125, 126 |
| Wide-complex tachycardia | adult | 12 mg | IV/IO | not captured | standing | pages 73, 126 |
| Wide-complex tachycardia | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 73, 126 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 63, 77, 120, 127 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 63, 77, 120, 127 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 103 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 66, 122 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 66, 122 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 122 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 71, 72, 73, 126 |
| Narrow-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 71, 72, 73, 126 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | page 68 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 70, 124 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 70, 124 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 124 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | page 143 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | pages 65, 70, 89, 133 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | pages 65, 70, 89, 133 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 60 mg/kg | IV/IO | not captured | standing | pages 65, 70, 89, 133 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 60 mg/kg | IV/IO | not captured | standing | pages 65, 70, 89, 133 |
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | pages 65, 70, 74, 121 |
| Hyperkalemia | peds | 60 mg/kg | IV/IO | not captured | standing | pages 65, 70, 74, 121 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 109 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 141 |
| Other | adult | 500 mg | TOP | not captured | standing | page 141 |
| Other | adult | 500 mg | PO | not captured | standing | page 141 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 109 |
| Other | peds | 60 mg/kg | IV/IO | not captured | standing | page 141 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IO/IM | not captured | standing | pages 97, 105, 194 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 105 |
| Other | adult | 2 g | IV/IO/IM | not captured | standing | page 81 |
| Other | adult | 2 g | IV/IO/IM | not captured | standing | page 97 |
| Other | peds | 50 mg/kg | IV/IO/IM | not captured | standing | pages 97, 105, 194 |
| Other | peds | 50 mg/kg | IV/IO/IM | not captured | standing | page 97 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | page 105 |
D–F Dexamethasone, Dextrose, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Etomidate, Fentanyl8
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 10 mg | IV/IO/IM/PO | not captured | standing | pages 62, 77, 119, 127, 195 |
| Allergic reaction | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | pages 62, 77, 119, 127, 195 |
| Respiratory distress | adult | 10 mg | IV/IO/IM/PO | not captured | standing | pages 63, 120, 195 |
| Respiratory distress | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | pages 63, 120, 195 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 250 mL | IV/IO | not captured | standing | pages 78, 129, 196 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 78, 129, 196 |
| Other | peds | 2–4 mL/kg | IV/IO | not captured | standing | pages 115, 129 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | pages 71, 72, 197 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25 mg | PO | not captured | standing | pages 77, 127, 198 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 77, 127, 198 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 77, 127, 198 |
| Allergic reaction | peds | 12.5 mg | PO | not captured | standing | pages 77, 127, 198 |
| Dystonic reaction | adult | 25 mg | IV/IO/IM | not captured | standing | pages 78, 92, 198 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 127 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO | not captured | standing | pages 79, 199 |
| Agitation | adult | 5 mg | IM | not captured | standing | pages 79, 199 |
| Nausea / vomiting | adult | 2.5 mg | IV/IO/IM | not captured | standing | pages 87, 199 |
| Other | adult | 2.5 mg | IV/IO/IM | not captured | standing | pages 82, 199 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | pages 77, 127 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 77, 127 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | pages 63, 120 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 63, 120 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 65, 66, 121, 122 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 65, 66, 121, 122 |
| Hypotension / shock | adult | 5–20 mcg | IV/IO | not captured | standing | pages 77, 84 |
| Hypotension / shock | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | pages 77, 84, 127 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 65, 121 |
| Stridor | adult | 2 mg | NEB | not captured | standing | pages 62, 119 |
| Stridor | peds | 0.01 mg/kg | IM | not captured | standing | pages 62, 119 |
| Stridor | peds | 2 mg | NEB | not captured | standing | pages 62, 119 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.15 mg/kg | IV/IO | not captured | standing | page 97 |
| Procedural sedation | adult | 0.15 mg/kg | IV/IO | not captured | standing | page 70 |
| Procedural sedation | adult | 0.15 mg/kg | IV/IO | not captured | standing | pages 72, 73 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM/IN | not captured | standing | pages 90, 134 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 90, 134 |
| Post-intubation sedation | adult | 1–2 mcg/kg | IV/IO | not captured | standing | page 60 |
| Procedural sedation | adult | 1–2 mcg/kg | IV/IO | not captured | standing | page 67 |
G–L Glucagon, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Labetalol, Levetiracetam, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV/IO | not captured | standing | pages 65, 70, 133 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 65, 70, 133 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 78, 129 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 78, 129 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 121 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 139 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 139 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 63, 77, 120, 127 |
| Asthma / bronchospasm | peds | 0.25 mg | NEB | not captured | standing | pages 63, 77, 120, 127 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 70 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | pages 72, 73 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 79 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 79 |
| Mild to moderate pain | adult | 0.2 mg/kg | IV/IO | not captured | standing | pages 90, 134 |
| Mild to moderate pain | adult | 0.4 mg/kg | IM | not captured | standing | pages 90, 134 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 90, 134 |
| Mild to moderate pain | peds | 0.4 mg/kg | IM | not captured | standing | pages 90, 134 |
| Severe pain | adult | 0.2 mg/kg | IV/IO/IN | not captured | standing | pages 90, 134 |
| Severe pain | peds | 0.2 mg/kg | IV/IO/IN | not captured | standing | pages 90, 134 |
| Post-intubation sedation | adult | 1 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
| Post-intubation sedation | peds | 1 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg | IV/IO/IM | not captured | standing | pages 90, 130, 210 |
| Other | peds | 0.5 mg/kg | IV/IO/IM | not captured | standing | pages 90, 130, 210 |
| Other | peds | 0.5 mg/kg | IM | not captured | standing | page 134 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV/IO | not captured | standing | page 113 |
| Other | adult | 5 mg | IV/IO | not captured | standing | pages 83, 113, 211 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 40 mg/kg | IV/IO | not captured | standing | pages 92, 107, 135, 212 |
| Other | peds | 40 mg/kg | IV/IO | not captured | standing | pages 92, 107, 135, 212 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IO | not captured | standing | page 56 |
| Other | adult | 0.5 mg/kg | IO | not captured | standing | page 90 |
| Other | adult | 100 mg | not captured | not captured | standing | page 106 |
| Other | adult | 40 mg | IO | not captured | standing | page 261 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 134 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 261 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | pages 56, 261, 213 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | pages 56, 261, 213 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5–4 mg | IV/IO/IM | not captured | standing | pages 79, 90, 134, 214 |
| Agitation | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | pages 79, 90, 134, 214 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose, Oxytocin10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | pages 113, 216 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 63, 120, 216 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 63, 120 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 66, 122 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | pages 63, 120, 216 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | pages 63, 120 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | pages 66, 122 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | pages 66, 73, 122, 126, 216 |
| Wide-complex tachycardia | peds | 50 mg/kg | IV/IO | not captured | standing | pages 66, 73, 122, 126, 216 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV/IO | not captured | standing | pages 62, 77, 119, 120, 127 |
| Allergic reaction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 62, 77, 119, 120, 127 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | pages 63, 120 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 63, 120 |
| COPD | adult | 125 mg | IV/IO/IM | not captured | standing | page 63 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.05 mg/kg | IV/IO | not captured | standing | pages 79, 134 |
| Agitation | adult | 0.1 mg/kg | IM/IN | not captured | standing | pages 79, 134 |
| Agitation | adult | 2.5 mg | IV/IO | not captured | standing | page 79 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 79 |
| Agitation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 79, 134 |
| Agitation | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 79, 134 |
| Alcohol withdrawal | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 78 |
| Alcohol withdrawal | adult | 0.1 mg/kg | IM/IN | not captured | standing | page 78 |
| Other | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 70 |
| Other | adult | 0.05 mg/kg | IV/IO | not captured | standing | pages 72, 73, 125, 126 |
| Other | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 89 |
| Other | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 67 |
| Other | adult | 0.1 mg/kg | IM/IN | not captured | standing | pages 72, 73, 125, 126 |
| Other | adult | 0.1 mg/kg | IM/IN | not captured | standing | page 89 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 72, 73, 125, 126 |
| Other | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 72, 73, 125, 126 |
| Post-intubation sedation | adult | 0.05 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
| Procedural sedation | adult | 0.1 mg/kg | IM/IN | not captured | standing | page 70 |
| Seizure | adult | 10 mg | IM/IN | not captured | standing | pages 92, 135 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | pages 92, 135 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 92, 135 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 92, 135 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 90 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1–4 mg | IN | not captured | standing | pages 78, 121, 128 |
| Opioid overdose | adult | 1–4 mg | IV/IO/IM | not captured | standing | pages 78, 128 |
| Opioid overdose | adult | 1–4 mg | IV/IO/IM/IN | not captured | standing | page 78 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 78, 121, 128 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 78, 128 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 128 |
| Other | peds | 2 mg | not captured | not captured | standing | page 121 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 61 |
| CHF / pulmonary edema | adult | 1 mg | IV/IO | not captured | standing | page 61 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 68 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–20 mcg | IV/IO | not captured | standing | page 107 |
| Hypotension / shock | adult | 2–20 mcg | IV/IO | not captured | standing | pages 84, 93, 107, 131 |
| Hypotension / shock | adult | 2–20 mcg | IV/IO | not captured | standing | page 84 |
| Hypotension / shock | peds | 0.05–0.2 mcg/kg | IV/IO | not captured | standing | pages 84, 93, 107, 131 |
| Hypotension / shock | peds | 0.05–0.2 mcg/kg | IV/IO | not captured | standing | page 107 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | SL/ODT | not captured | standing | pages 87, 132 |
| Nausea / vomiting | adult | 4 mg | SL/ODT | not captured | standing | pages 87, 132 |
| Nausea / vomiting | adult | 4–8 mg | IV/IM/IN | not captured | standing | pages 87, 132 |
| Nausea / vomiting | peds | 0.1 mg/kg | SL/ODT | not captured | standing | pages 87, 132 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | pages 87, 132 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 78, 129 |
| Hypoglycemia | peds | 7.5 g | PO | not captured | standing | pages 78, 129 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 113 |
P–R Plasma, Rocuronium2
Plasma
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 109 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
S–Z Sodium Bicarbonate, Tranexamic Acid, Vecuronium, Whole Blood4
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 65, 121, 126, 227 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 65, 121, 126, 227 |
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 103, 227 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 103, 227 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 74, 227 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 74, 227 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 101 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | pages 89, 126, 133, 227 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 89, 126, 133, 227 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1 g | IV/IO | not captured | standing | pages 113, 228 |
| Other | adult | 1 g | IN | not captured | standing | pages 88, 228 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 62 |
| Other | adult | 1 g | TOP | not captured | standing | page 88 |
| Other | adult | 1 g | IN | not captured | standing | page 88 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 107, 228 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 99 |
| Other | peds | 15 mg/kg | IV/IO | not captured | standing | page 99 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 99, 108, 228 |
| Trauma / hemorrhage | adult | 500 mg | NEB | not captured | standing | pages 88, 228 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | pages 99, 108, 228 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 60, 118 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | pages 109, 215 |
| Trauma / hemorrhage | peds | 10 mL/kg | IV/IO | not captured | standing | pages 109, 215 |
Cite this
Hays County ESD 9 EMS, United States EMS Protocol Census. 211 dose entries, effective 2026-07-01.
https://protoquiz.com/census/agencies/hays-county-esd-9-ems/
The census is free and not for sale. Only public agencies are named.